medigraphic.com

2005, Number 4

<< Back Next >>

Rev Mex Anest 2005; 28 (4)

Anesthetic management of illicit-drug user

Rivera-Flores J, Chavira-Romero M

Language: Spanish
References: 133
Page: 217-232
PDF size: 131.41 Kb.


ABSTRACT

The use of illicit drugs or psychotropic substances has increased in the past few years, despite the efforts by governments in many countries to stem it. This is due to the fact that the cost of some drugs has been reduced through the combination with other substances or adulterants (cut), so that low-income population also has access to them. Drug use, both acute and long-term, may lead to problems during anesthetic management, since the various drugs can either potentiate or decrease the effects of some anesthetic drugs. Monitoring varies according to the surgery the patient will undergo, the type of illicit drug, and whether its use is acute or chronic. Although there are certain anesthetics that may be used uneventfully, the use of each substance must be considered on an individual basis.


REFERENCES

  1. Rivera FJ, Chavira RM. Pacientes con adicciones. En: Texto de anestesiología teórico-práctica. Aldrete J, Guevara López U, Capmourteres EM. Eds. El Manual Moderno. México, D.F. 2ª Ed. 2004:1227-37.

  2. Siegel RK. Changing patterns of cocaine use; longitudinal observations, consequences and treatment. NIDA Res Monogr Ser 1984;50:92-110.

  3. Borges,G. Adicciones problema de salud pública. Cuadernos de Nutrición 1996;19(4):21-9.

  4. Yuguero J. Drogodependencias. Medicine 1988;45(5):87-107.

  5. Amara H, Zuckerman B, Cabral H. Drug use among adolescent mothers: Profile of risk. Pediatrics 1989;84:144.

  6. Lomelí GM, García TBE. Drogas y mujeres adictas en cárceles. Rev Fac Med 1999;42:151-54.

  7. Pham-Tourreau, Nizard V, Pourriat JL. Anestesia en pacientes drogadictos. In: Alhomme P, Bunodière M, Guidon C, et al. Eds. Encycl Méd Chir. Anestesia Reanimación. Elsevier SAS 2001;36-659-A-10:1-12.

  8. Rivera FJ, Chavira RM. El paciente farmacodependiente traumatizado: manejo anestésico. Rev Mex Anest 2004;27(Spl. 1):S167-9.

  9. Rivera FJ. Alcohol, trauma y anestesia. Memorias XXIV Curso Anual Actualización en Anestesiología. SMA 1998:1-5.

  10. Rivera FJ, Campos VAF. Anestesia en paciente embarazada farmacodependiente. En: JGH Eds. Anestesia obstétrica. Dr. Canto Sánchez L. Ed. Manual Moderno. México, D.F. 2001:597-612.

  11. Sistema de Encuestas de Salud. Encuesta Nacional de Adicciones 1998. SSA; México. 1998.

  12. Stymson GV, Labrousse A, Costa L, Pimenta P. II Conferencia Nacional sobre Conferencia de drogas. Intercambiando 2004:6.

  13. Del Moral MM, Lorenzo P. Conceptos fundamentales en drogodependencias. En: Drogodependencias. Lorenzo P, Ladero JM, Leza JC, Lizasoain I. Eds. Editorial Médica Panamericana. Madrid, Esp. 2003:3-26.

  14. Frances A, Pincus HA, First MB. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM IV 4a. Ed. Washington, D.C. 1994.

  15. Organización Mundial de la Salud (OMS). CIE-10. Ed. Meditor. Trastornos Mentales y del Comportamiento. Madrid, España. 1992.

  16. Ramos JA, Fernández R J. Mecanismos neuroquímicos de la drogodependencia. En: Lorenzo P, Ladero JM, Leza JC, Lizasoain I. Eds. Drogodependencias. (Farmacología, Patología, Psicología, Legislación). 2ª Ed. Panamericana. Madrid, Esp. 2003:57-68.

  17. May JA, White HC, White AL, Warltier DC, Pagel PS. The patient recovering from alcohol or drug addiction: special issues for the anaesthesiologist. Anesth Analg 2001;92:1601-8.

  18. Kelley AE, Berridge AC. The neuroscience of natural rewards: relevant to addictive drugs. J Neurosc 2002;22:3306-11.

  19. May JA, White HC, et al. The patient recovering from alcohol or drug addiction: special issues for the anesthesiologist. 2001;92:1601-8.

  20. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science 1997;278:58-63.

  21. Berke JD. Addiction, dopamine and the molecular mechanisms of memory. Neuron 2000;25:515-32.

  22. Goldstein A. Neurotransmisores: las drogas del propio cerebro. En: Adicción: de la biología a la política de drogas. Medicina STM Editores, S.L. Barcelona, Esp. 2003:17-32.

  23. Johnston LD, O’Malley PM, Bachman JG. (2001) Monitoring the Future: National Survey Results on Drug Use, 1975-2000. Bethesda, MD: National Institute on Drug Abuse Volume 1: Secondary School Students (NIH Publication No. 01-4924.

  24. Rodríguez PC, Echaniz AL. El café: droga socialmente aceptada. Cuadernos de Nutrición 1996;19:30-3.

  25. Hoffman RS, Goldfrank LR. El impacto del consumo de drogas y de la adicción sobre la sociedad. Clin Med Urg NorteAm 1990;3:533-549.

  26. Sobel, K. NIDA AIDS projects succeed in reaching drug addicts, changing high-risk behaviors. NIDA Notes 1991;6:25-7.

  27. Fried PA, Watkinson B, Grant A, et al. Changing patterns of soft drug use prior to and during pregnancy: A prospective study. Drug Alcohol Depend 1980;6:323.

  28. Deniker P. Drogues et toxicomanies modernes. Ann Med Psychol 1970;2:68-70.

  29. Del Moral MM, Lorenzo P. Fundamentos biopsicosociales en drogodependencias. Prevención y tratamiento. En: Lorenzo P, Ladero JM, Leza JC, Lizasoain I. Eds. Drogodependencias. (Farmacología, Patología, Psicología, Legislación). 2ª Ed. Panamericana. Madrid, Esp. 2003:27-55.

  30. Hoenicka J, Ramos JA. Aspectos genéticos de las drogodependencias. En: Lorenzo P, Ladero JM, Leza JC, Lizasoain I. Eds. Drogodependencias. (Farmacología, Patología, Psicología, Legislación). 2ª Ed. Panamericana. Madrid, Esp. 2003:69-81.

  31. Crabbe JC. Genetic contributions to addiction. Annu Rev Psychol 2002;53:435-62.

  32. Hirschhorn JN, et al. A comprensive review of genetic association studies. Genet Med 2002;4:45-61.

  33. Goldstein A. Los adictos nacen o se hacen? En: Adicción: de la biología a la política de drogas. Medicina STM Editores, S.L. Barcelona, Esp. 2003:99-114.

  34. Cheng DC. The drug addicted patient. Can J Anaesth 1997;44:R101-11.

  35. American College Of Physicians Health and Public Policy Committee: Chemical dependence. Ann Intern Med 1985;102:485.

  36. Rivera FJ. Anestesia en el paciente traumatizado con intoxicación etílica. XXVII Congreso Latinoamericano de Anestesiología (CLASA). San Salvador, El Salvador. 2001:49-51.

  37. Rivera FJ. Alcoholismo y anestesia. Anest Méx 1999;11(Spl. 1)125-6.

  38. Naudé PG. Alcohol y abstinencia aguda. En: Naudé GP, Bongard FS, Oemetriades O. Secretos del traumatismo. 1ª Ed McGraw-Hill Interamericana. 2000:273-6.

  39. Thal ER, et al. Effects of alcohol and other drugs on traumatized patients. Arch Surg 1985;120:708-12.

  40. Lucas ChE, Ledgerwood AM, Kline RA. Alcohol y drogas. En: Mattox KL, Feliciano DV, Moore EE. Eds. McGraw-Hill Interamericana. Trauma 2001:1127-45.

  41. Pavlin EG. Abuso del etanol y de otras sustancias en pacientes traumatizados. En: Grande CM. Tratado de Anestesia en el paciente traumatizado y en cuidados críticos. 1994:779-88.

  42. Gelb AM, Mildvan D, Stenger RJ. The spectrum and causes of liver disease in narcotic addicts. Am J Gastroenterol 1997;67:314.

  43. Haverkos H, Lange W. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis 1990;161:984.

  44. Moss AR. AIDS and intravenous drug use: the real heterosexual epidemic. Br Med J 1987;294:389.

  45. Ebeling F. Epidemiology of the hepatitis C virus. Vox Sanguinis 1998;74(Suppl 2):143-6.

  46. Santos AC. Anesthetic management of parturients with substance abuse or HIV. Rev Mex Anest. 2002;2(Suppl 1)124-5.

  47. Vertommen JD, Levinson G, Shnider S. Anesthesia and drug mother. Anaesthesia in Obstetrics. Baltimore. Williams and Wilkins. 1993:633-43.

  48. Fábregas N. Anestesia en la embarazada drogadicta. En: Taurá P. Anestesia en la paciente obstétrica de alto riesgo. EDIKAMED Barcelona, Esp. 1999:261-73.

  49. Wheeler SF. Abuso de sustancias tóxicas durante el embarazo. Clin Atn Prim 1993;1:229-49.

  50. Voigt L. Anesthetic management of the cocaine abuse patient. AANA-J 1995;63(5):438-43.

  51. Scher MS, Richardson GA, Day NL. Effects of prenatal/crack and other drug exposure on electroencephalographic sleep studies at birth and one year. Pediatrics 2000;105(1 Pt 1):39-48.

  52. Hogerman G, Schnoll S. Uso de narcóticos durante el embarazo. Clin Perinatol 1991;1:55-80.

  53. Hayford SM, Epps RP, Dahl Regis M. Behavior and development patterns in children born to heroin addicted and methadone mainteined mothers. J Natl Med Asso 1988;80:1197-200.

  54. Erickson M, Carson G, Zeterstrom R. Amphetamine addiction and pregnancy. Acta Obstet Gynecol Scand 1981;60:253.

  55. Vailliant GE. The natural history of alcoholism. Cambridge, MA: Harvard University Press, 1983.

  56. Swan, N. Treatment practitioners learn about LAAM. NIDA Notes. 1994;9:5.

  57. Holloway M. Treatment for addiction. Sci Am 1991;263:70.

  58. Moore RD, Bone LR, Geller G, et al. Prevalence, detection, and treatment of alcoholism in hospitalized patients. JAMA 1989:261:403-10.

  59. Johnson SF, McCarter RJ, Ferencez C. Changes in alcohol, cigarette and recreational drug use during pregnancy: Implications for intervention. Am J Epidemiol 1987;126:695.

  60. Hoffman RS, Goldfrank LR. El impacto del consumo de drogas y de la adicción sobre la sociedad. Clin Med Urg NorteAm 1990;3:533-549

  61. Zacny J, Galinkin JL. Psychotropic drugs used in anesthesia practice: Abuse liability and epidemiology of abuse. Anesthesiology 1999;90:269-88.

  62. Dillman JM. Substance abuse in the perioperative setting. AORNJ 1995;62:111-2.

  63. Frost EA, Seidel MR. Valoración preanestésica del paciente con abuso de drogas. Clin Anesth NorthAm 1990(4):781-93.

  64. Beattie CH, Lewis TC, Mark LJ. Evaluation of the patient with Alcoholism and other Drug Dependences. In: Longnecker DE, Tinker JH, Morgan GE Jr. Ed. Mosby St. Louis. 1998:528-554.

  65. Carr LA. Farmacología de las drogas de abuso psicoactivas. Clin Atn Prim 1993;1:23-36.

  66. Dillman JM. Substance abuse in the perioperative setting. AORN-J.1995;62:111-112.

  67. Veit AM, Fitzpatrick K. Alcoholismo. En: Duke J, Rosenberg SG. Secretos de la Anestesia. MacGraw Hill-Interamericana Philadelphia. 1996:407-14.

  68. Spies C, Neuner B, Neumann T, et al. Intercurrent complications on chronic alcoholics admitedd to the intensive care unit following trauma. Intensive Care Med 1996;22:286-93.

  69. Rodríguez MA, Zapata IL. Hepatopatía por alcohol. Rev Med Int Méx 1996;12:105-9.

  70. Bleich HL, Boro ES. Metabolic and hepatic effects of alcohol. N Engl J Med 1977;296:612-16.

  71. Chamess ME, Simon RP, Greenberg DA. Alcohol and the nervous system. N Engl J Med 1989;321:442-54.

  72. Agelink MW, Malessa R, Weiser U, et al. Alcoholism, peripheral neuropathy (PNP) and cardiovascular autonomic neuropathy (CAN). J Neurol Sci 1998;161:135-142.

  73. Lieber CS. Medical disorders of alcoholism. N Engl J Med 1995;333:1058-65.

  74. Rivera Flores J, Chavira Romero M. Manejo anestésico del paciente con alcoholismo. Rev Mex Anest 2004;27:97-106.

  75. Ashton C. Adverse effects of cannabis and cannabinoids. Br J Anaesth 1999;83:637-49.

  76. White MC, Reynolds F. Sudden airway obstruction following inhalation drug abuse. B J Anaesth 1999;82:808.

  77. Estroff TW, Gold MS. Psychiatric aspects of marijuana abuse. Psych Ann 1986;16:221-24.

  78. Murray JB. Marijuana’s effects on human cognitive functions, psichomotor functions and personality. J Gen Psycol 1986;113:23-55.

  79. Thomas H. A community survey of adverse effects of cannabis use. Drug Alcohol Depend 1996;42:201-7.

  80. Voth EA, Schwartz RH. Medical applications of D 9-tetrahidrocannabinol and marijuana. Ann Intern Med 1997;126:791-8.

  81. H Kalant, et al. Eds. Health Effects of Cannabis. Toronto, Can. ARF Books. 1999.

  82. Ashton CH. Adverse effects of cannabis and cannabinoids. Br J Anaesth 1999;83:637-49.

  83. Carabez Trejo A. Inhalación de disolventes industriales. Gac Med Mex 1994;130(5):325-36.

  84. Linden CH. Adicción a sustancias volátiles. Clin Med Urg NA 1990;3:643-65.

  85. Balster RL. Neural basis of inhalant abuse. Drug Alcohol Depend 1998;3:248-54.

  86. Díaz JL. Las plantas mágicas y la conciencia visionaria. ArqueoMex 2003;10:16-31.

  87. Erickson M, Arson G, Zeterstrom R. Amphetamine addiction and pregnancy. Acta Obstet Gynecol Scand 1981;60:253.

  88. Aaron CK. Simpatomiméticos. Clin Med Urg NortAm 1990;3:587-603.

  89. Morgan MJ. Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology 2000;152:230-48.

  90. Lorenzo P. MDMA y otras feniletilaminas. Farmacología y toxicología general. En: Éxtasis (MDMA): Un abordaje comprensivo. Ed. Masson. 1998:15-39.

  91. Miller DB, O’Callaghan JP. Environment –drug- and stress induced alterations in body temperature affecct neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 1994;270:752-60.

  92. Abraham HD, Aldridge AM, Logia P. The psychopharmacology of hallucinogens. Neuropsychopharmacology 1996;14:285-98.

  93. Ungerleider JT, Pechnick RN. Alucinógenos. En: M Galanter, HD Kleber Eds. Tratamiento de los trastornos por abuso de sustancias. Barcelona, Esp. Ed. Masson. 1997:141-47.

  94. Bernards CM, Teijeiro A. Illicit cocaine ingestion during Anesthesia. Anesthesiology 1996;84(1):218-20.

  95. Cheng D. Perioperative care of the cocaine-abusing patient. Can J Anaesth 1994;41(10):883-7.

  96. Young D, Glauber JJ. Electrocardiographic changes resulting from acute cocaine intoxication. Am Heart J 1997;34:272-9.

  97. Virmani R, Robinowitz M, Smialeck J, Smyth DF. Cardiovascular effects of cocaine: an autopsy study of 40 Patients. Am Heart J 1988;115:1068-76.

  98. Cregler LL, Mark H. Medical complications of cocaine abuse. N Engl J Med 1986;315:1495.

  99. Burday MJ, Martin ES. Cocaine induced thrombocytopenia. Am J Med 1991;91:656-60.

  100. Artwright TR, brown D, Brashear RAE. Pulmonary infiltrates following butane “fire breathing” Arch Intern Med 1983; 143:2007-8.

  101. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med 2001;345:351-8.

  102. Benowitz NL. Clinical pharmacology of caffeine. Annu Rev Med 1990;41:277-88.

  103. Holtzman SG. Caffeine as a model drug abuse. Trends Pharmacol Sci 1990;11:355-6.

  104. Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanism of action, biochemical, metabolic and psycgostimulant effects. Brain Res Rev 1992;17:139-70.

  105. Heningfield JE, Goldberg SR. Nicotine as a reinforce in human subjects and laboratory animals. Pharmacol Biochem Behav 1983;19:989.

  106. Russell CS, Taylor R, Maddison RN. Some effects of smoking in pregnancy. J Obstet Gynaecol Br Cowlth 1966;73:742.

  107. Pontieri F, Tanda G, Orzi F, Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996;382:255-7.

  108. Warburton DM. Nicotine issues. Psychopharmacology 1992;108:393-6.

  109. Dellemign PL, Fields H. Do benzodiacepines have a role in chronic pain management? Pain 1994;57:137-52.

  110. Griffiths R, Wolb B. Relative abuse liability benzodiazepines in drug abusers. J Clin Psychopharmacol 1990;10:237.

  111. Ashton H. The treatment of benzodiazepines dependence. Addiction 1994;89:1535-41.

  112. Busto UE. Factores de riesgo en el abuso y la dependencia a benzodiacepinas. Trastornos Adictivos 2000;2:177-82.

  113. Lader M. Biological processes in benzodiazepines dependence. Addiction 1994;89:1413-18.

  114. Woods JH, France CP, Winger GD. Behavioral pharmacology of buprenorphine: issues relevant to its potential in treating drug abuse. In: Blain, JD, ed. Buprenorphine: An Alternative for Opiate Dependence. National Institute on Drug Abuse Research Monograph 121. DHHS Pub. No. (ADM) 92-1912. Washington, DC: Supt. of Docs., U.S. Govt. Print. Off.,1992, pp. 12-27.

  115. Sternbach G, Moran J, Eliastam M. Heroin addiction: acute presentations of medical complications. Ann Emerg Med 1980;9:161.

  116. Savage SR. Addiction in the treatment of pain: significance, recognition, and management. J Pain Symptom Management 1993;8:265.

  117. De Vries TJ, Shippenberger T. Neural systems underlyng opiate addiction. J Neurosci 2002;22:3321-25.

  118. Li J, Stokes SA, Woeckener A. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management. Ann Emerg Med 1998;31:729-36.

  119. Kenepp N, Chatwani A. Substance abuse. In: Datta S. Anesthetic and obstetric management of high-risk pregnancy. Mosby St Louis. 1996:498-528.

  120. Word PR, Soni N. Anaesthesia and substance abuse. Anaesthesia 1989;149:2071.

  121. Boylan J, Cheng DCH, et al. Cocaine isofluorane interaction in swin: regional blood flow effects. Anesth Analg 1993;76:S26.

  122. Bernards CM, Teijeiro A. Illicit cocaine ingestion during anesthesia. Anesthesiology 1996;84:218-20.

  123. Cooke JE, Vila H, Kaplan R. Anesthetic complication 14 hours after the use of crack cocaine. Anesth Analg 1993;76:676-77.

  124. Liu SS, Forrester RM, Murphy GS. Anesthetic management of a parturient with myocardial infarction related to cocaine use. Can J Anaesth 1992;39:858-61.

  125. Boylan J, Cheng DCH. Cocaine, isofluorano interaction in swine: regional blood flow effects. Anesth Analg 1993;76:S26.

  126. May J, White HC, White AL, Warltier DC, Pagel PS. The patient recovering from alcohol or drug addiction: Special issues for the Anesthesiologist. Anesth Analg 2001;92:1601-8.

  127. Tsutsumi R, et al. Interaction of etanol and enflurane metabolism and toxicity: role of P 45011E1 Alcohol Clin Exp Res 1990;14:174.

  128. Bruce DL. Alcoholism and anesthesia. Anesth Analg 1983;62:84-96.

  129. Pohorecky LA, Shah P. Etanol-induced analgesia. Life Sci 1987;41:1289-95.

  130. Zinn SE, Fairley HB, Glenn M. Liver function in patients with mild alcoholic hepatitis, alter enflurane, nitrous oxide-narcotic, and spinal anestesia. Anesth Analg 1985;64:487-90.

  131. Copeland J. Developments in the treatment of cannabis use disorder.Curr Opin Psychiatry 2004;17:161-67.

  132. Klock PA. Drug interactions for the Anesthesiologist. 53 Annual Refresher Course Lectures. Annual Meeting ASA. 2002:111(1-7).

  133. Kain ZN. Anesthetic implications of drug abuse. 53 Annual Refresher Course Lectures. Annual Meeting ASA. 2002:156(1-7).




2020     |     www.medigraphic.com